Jordan ML - Search Results

1

Inhibition of T-cell function by FK 506 and cyclosporine is not accompanied by alterations in intracellular calcium.

Jordan ML, Hignet S, Wright J, Hoffman RA, Starzl TE. Jordan ML, et al. Transplant Proc. 1991 Dec;23(6):2950-2. Transplant Proc. 1991. PMID: 1721323 Free PMC article. No abstract available.

2

Pediatric renal transplantation under FK 506 immunosuppression.

Jensen CW, Jordan ML, Schneck FX, Shapiro R, Tzakis A, Hakala TR, Starzl TE. Jensen CW, et al. Among authors: jordan ml. Transplant Proc. 1991 Dec;23(6):3075-7. Transplant Proc. 1991. PMID: 1721364 Free PMC article. No abstract available.

3

Transplantation of pediatric en bloc kidneys under FK 506 immunosuppression.

Darras FS, Jordan ML, Shapiro R, Sundberg R, Scantlebury VP, Jensen CW, Hakala TR, Starzl TE. Darras FS, et al. Among authors: jordan ml. Transplant Proc. 1991 Dec;23(6):3089-90. Transplant Proc. 1991. PMID: 1721368 Free PMC article. No abstract available.

4

Sustained increases in cytosolic calcium during T lymphocyte allosensitization, proliferation, and acquisition of locomotor function.

Jordan ML, Vidgen DF, Wright J, Odell M, Mills GB. Jordan ML, et al. Transplantation. 1991 Feb;51(2):464-8. Transplantation. 1991. PMID: 1825245

5

Tacrolimus rescue therapy for renal transplant rejection.

Jordan ML, Shapiro R, Naraghi R, Smith D, Vivas C, Gritsch HA, Scantlebury V, Randhawa P, Demetris AJ, Fung JJ, Starzl TE. Jordan ML, et al. Transplant Proc. 1996 Aug;28(4):2119-20. Transplant Proc. 1996. PMID: 8769174 Free PMC article. Clinical Trial. No abstract available.

6

Five-year experience with tacrolimus rescue for renal allograft rejection.

Jordan ML, Naraghi RN, Shapiro R, Smith D, Vivas CA, Scantlebury VP, Gritsch HA, McCauley J, Randhawa P, Demetris AJ, McMichael J, Fung JJ, Starzl TE. Jordan ML, et al. Transplant Proc. 1997 Feb-Mar;29(1-2):306. doi: 10.1016/s0041-1345(96)00272-2. Transplant Proc. 1997. PMID: 9123009 Free PMC article. No abstract available.

7

Cadaveric renal transplantation against a positive historic crossmatch under tacrolimus immunosuppression: long-term follow-up.

Lyne JC, Vivas CA, Shapiro R, Scantlebury VP, Hakala TR, Starzl TE, Jordan ML. Lyne JC, et al. Among authors: jordan ml. Transplant Proc. 1997 Feb-Mar;29(1-2):312. doi: 10.1016/s0041-1345(97)82527-4. Transplant Proc. 1997. PMID: 9123015 Free PMC article. No abstract available.

8

Genetically determined leukotriene B4 production is not required for cytotoxic effector cell development during allograft rejection.

Gignac MR, Chatlos LJ, Hoffman RA, Gritsch HA, Jordan ML. Gignac MR, et al. Among authors: jordan ml. Transplant Proc. 1997 Feb-Mar;29(1-2):1052. doi: 10.1016/s0041-1345(96)00370-3. Transplant Proc. 1997. PMID: 9123193 No abstract available.

9

Pancreas transplantation without antibody therapy.

Corry RJ, Shapiro R, Egidi MF, Jordan ML, Scantlebury V, Vivas C, Gritsch HA, Starzl TE. Corry RJ, et al. Among authors: jordan ml. Transplant Proc. 1998 Mar;30(2):299-300. doi: 10.1016/s0041-1345(97)01415-2. Transplant Proc. 1998. PMID: 9532050 Free PMC article. No abstract available.

10

Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients.

Corry RJ, Egidi MF, Shapiro R, Sugitani A, Gritsch HA, Jordan ML, Dodson SF, Vivas CA, Scantlebury VP, Rao AS, Fung JJ, Starzl TE. Corry RJ, et al. Among authors: jordan ml. Transplant Proc. 1998 Mar;30(2):521. doi: 10.1016/s0041-1345(97)01385-7. Transplant Proc. 1998. PMID: 9532157 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters